Text
Targeting L-kynurenine metabolism could be a therapeutic strategy for managing Crohn’s disease.
The findings suggest that the composition of the gut microbiota in early life is not a key factor in obesity risk.
New research has now uncovered differences in the gut microbiota composition between people with the condition and those without.
Specific gut microbiota features correlate with better responses to immunotherapy in people with melanoma.
The study revealed that MS-20 dramatically improved treatment outcomes, tripling the objective response rate (ORR) to 75% when combined with Keytruda.
Including microbial load in microbiota studies can help researchers better understand how gut bacteria influence diseases, leading to more accurate diagnoses and effective treatments.
The findings highlight the importance of maintaining a healthy microbiota after EEN and suggest that personalized dietary approaches can help induce remission for children with Crohn’s disease.
The findings suggest that gut microbes and LPC are potential therapeutic targets for Alzheimer's disease.
Researchers have identified a new class of virus-like agents known as "obelisks" in oral and stool samples from hundred of people.
This article presents “The Cancer Microbiota Database," an interactive and customizable tool to investigate 33 types of cancers.
